Inotiv, Inc. (NASDAQ:NOTV) CEO Sells $94,205.00 in Stock

Inotiv, Inc. (NASDAQ:NOTV) CEO Robert Jr. Leasure sold 22,700 shares of Inotiv stock in a transaction on Friday, January 31st. The shares were sold at an average price of $4.15, for a total value of $94,205.00. Following the completion of the sale, the chief executive officer now directly owns 1,030,209 shares of the company’s stock, valued at $4,275,367.35. This trade represents a 2.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website.

Inotiv Trading Up 1.6 %

Shares of NASDAQ NOTV traded up $0.07 during midday trading on Tuesday, hitting $4.50. The stock had a trading volume of 1,028,851 shares, compared to its average volume of 613,780. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.37 and a quick ratio of 1.22. Inotiv, Inc. has a fifty-two week low of $1.23 and a fifty-two week high of $11.42. The company’s 50-day simple moving average is $4.39 and its 200 day simple moving average is $2.77. The firm has a market cap of $117.05 million, a P/E ratio of -1.07 and a beta of 3.58.

Inotiv (NASDAQ:NOTV) last announced its quarterly earnings data on Tuesday, December 3rd. The company reported ($0.16) EPS for the quarter. Inotiv had a negative return on equity of 15.86% and a negative net margin of 22.10%. Research analysts anticipate that Inotiv, Inc. will post -0.75 EPS for the current year.

Institutional Investors Weigh In On Inotiv

Institutional investors have recently made changes to their positions in the stock. AlphaCentric Advisors LLC acquired a new stake in shares of Inotiv during the fourth quarter worth $163,000. Renaissance Technologies LLC lifted its holdings in Inotiv by 29.9% during the second quarter. Renaissance Technologies LLC now owns 164,164 shares of the company’s stock worth $273,000 after acquiring an additional 37,800 shares in the last quarter. Calamos Advisors LLC bought a new position in Inotiv during the fourth quarter worth about $275,000. Geode Capital Management LLC lifted its holdings in Inotiv by 7.7% during the third quarter. Geode Capital Management LLC now owns 250,895 shares of the company’s stock worth $427,000 after acquiring an additional 18,039 shares in the last quarter. Finally, Nkcfo LLC bought a new position in Inotiv during the fourth quarter worth about $476,000. 18.17% of the stock is owned by institutional investors and hedge funds.

Inotiv Company Profile

Inotiv, Inc provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries. It operates through two segment: Discovery and Safety Assessment (DSA), and Research Models and Services (RMS). The DMS segment manufactured scientific instruments for life sciences research and the related software for use by pharmaceutical companies, universities, government research centers, and medical research institutions under the Company's BASi product line.